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Background: Limited data are available on the frequency of IgE mediated food sensitization and food allergy (FA)
in adults with atopic dermatitis (AD).
Objective: We investigated the pattern of food sensitization in adults with AD in relation to AD severity using
multiplexed allergen microarray.
Methods: 211 adult patients referred between January 2010-July 2011 for evaluation of AD were unselectively
included. Severity of AD was determined by therapy intensity, SASSAD-skin-score and sTARC levels. Allergen specific
sIgE levels were measured by ImmunoCAP ISAC® microarray. FA was defined as convincing history taken by
physician and sensitization to the corresponding allergen.
Results: Sensitization to food was found in 74.4% of the AD patients, 54% had a positive history of FA and 20.4%
asymptomatic sensitization. There was no association between severity of AD and frequency of food sensitization or
history of FA.
Sensitization to PR-10 related food allergens occurred most frequently (63.5%) and was independent from AD
severity. Correspondingly, pollen-food syndrome accounted for most of the FA, being also independent from AD
severity. Of all plant food allergens only sensitization to nAra h 1 was significantly more frequent in patients with
severe AD. In the total group 75 (35.5%) patients with AD showed sensitization to any animal food allergen. The
percentage was significantly higher in patients with severe AD (51.4%) compared to patients with mild/moderate
AD (27.7%). Sensitization to cow’s milk allergens, in particular to nBos d lactoferrin, was more frequent in severe AD
patients.
Conclusion: AD was frequently associated with food sensitization. The percentage of sensitization to animal food
allergens was significantly higher in severe AD patients.
Keywords: Atopic dermatitis, Component-resolved diagnostics, IgE food sensitization, Multiplexed allergen
microarrayBackground
Atopic dermatitis (AD) is a chronic inflammatory skin
disease that commonly begins in early infancy and runs
a course of exacerbations and remissions. AD is often
accompanied by other atopic features such as asthma, al-
lergic rhino conjunctivitis and food allergy [1,2]. AD af-
fects 1-3% of adults world-wide [3]; the prevalence of
immediate type FA in adults is 2-3% [4]. In infants with* Correspondence: h.rockmann@umcutrecht.nl
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article, unless otherwise stated.AD the prevalence of immediate type FA was estimated
to be 30% [2,5,6]. So far data on the frequency of imme-
diate type FA in adult patients with AD are scarce and
show a wide variation (33% versus 73%) dependent on
study design [7-9]. In addition, there are no data on the
association between severity of AD in adults and food
sensitization pattern.
Allergen specific IgE sensitization (symptomatic as well
as asymptomatic) to a wide spectrum of food-and aeroal-
lergens is a common phenomenon in adult patients with
AD; especially sensitization to house dust mite, pollen and
(pollen-related cross-reactive) food allergens is frequentlytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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group of adult AD patients using component resolved
diagnostics was only investigated in a small German popu-
lation (n = 20) [11] describing a sensitization frequency of
70% to PR-10 related food allergens, 45% to animal food
and 30% to CM allergens. However, comparison of pa-
tients depended on AD severity was not done.
Routine tools for detection of sensitization are in-vivo
skin prick testing (SPT) with allergens or in-vitro deter-
mination of allergen specific IgE in serum by Immuno-
CAP® [12]. The newly developed microarray (ImmunoCap
ISAC®) incorporates recombinant or purified allergen
components from more than 50 allergenic sources, allow-
ing determination of specific immunoglobulin E (IgE)
against currently more than 130 specific allergen compo-
nents from the same serum sample [13-16]. Notably,
measuring allergen specific IgE only detects sensitization.
Until now, no data are available on the relation between
the pattern of IgE mediated food sensitisation and severity
of AD in adults. In this retrospective study we investigated
the frequency and type of food sensitization in adult pa-
tients with AD in relation to AD severity.
Methods
All patients (aged ≥16 years) diagnosed with AD who visited
the outpatient clinic of the department of Dermatology/
Allergology of the University Medical Center Utrecht be-
tween January 2010- July 2011 were retrospectively ana-
lyzed. All patients were primary referred to our hospital
for evaluation and treatment of AD. Inclusion criteria
were: reference due to evaluation of AD, diagnosis of AD,
clinical data about AD therapy, specific IgE determined by
ImmunoCap ISAC® microarray. Exclusion criteria were:
uncertainty about AD diagnosis. Data on AD (present and
previous therapy; SASSAD [17] [Six Area, Six Sign Atopic
Dermatitis] skin score, sTARC [18] [serum thymus and
activation-regulated chemokine], FA in patient history
(type of food, symptoms, severity of reaction) and other
atopic features (asthma, seasonal allergic rhino con-
junctivitis, allergy to animal dander) were obtained from
patient records.
The medical ethics committee of University Medical
Center Utrecht confirmed that the Medical Research
Involving Human Subjects Act (WMO) does not apply to
the study.
Atopic dermatitis
Diagnosis of AD was made according to the UK criteria
of Williams [19]. Severity of AD was defined based on
the therapy the patients received to control their disease.
Patients using topical steroids to control their disease
were defined having mild/moderate AD. Patients who
were prescribed oral immunosuppressive drugs continu-
ously for more than 3 months in the previous 5 yearswere defined as having severe AD. Clinical eczema se-
verity scores (SASSAD; severity range 0 to108), serum
total IgE and sTARC at patient’s first visit to the out-
patient clinic were available in a subgroup and used for
the confirmation of the classification based on therapy.
Concentrations of sTARC were determined using the
Human TARC Immunoassay which was performed ac-
cording to the manufacturer’s instructions (R&D systems,
Minneapolis, USA).
IgE measurement
Specific IgE levels were routinely measured using a
microarray immunoassay (Immuno Solid-phase allergen
Chip (ImmunoCAP ISAC®, VBC Genomics and Phadia)
with 103 allergens, (see Additional file 1: Table S1 in
the Online Repository) in every adult patient with AD
visiting the outpatient clinic from January 2010 to
July 2011. A value of < 0.3 ISU/L was considered nega-
tive; sensitization was defined as at least one food allergen
on the ISAC® > 0.3 ISU/L. Median serum level and inter-
quartile range (IQR) was assessed in patients with values ≥
0.3 ISU/L.
Total IgE levels were routinely measured using Immu-
noCAP (Phadia®). Levels > 5000 kU/l were not further
titrated.
Food allergy
FA was defined as a convincing history (taken by an
experienced physician) of immediate type symptoms
(oral allergy symptoms, urticaria, angioedema, conjunctiv-
itis, rhinitis, vomiting, diarrhea, dyspnea, hypotension,
anaphylactic shock) within 2 hours after intake of the cul-
prit food in combination with sensitization to at least one
corresponding allergen on the ISAC®.
Considering each food item separately, severity of the
FA-related symptoms according to history (taking into
account the most severe reaction) was classified accord-
ing to a modification of the Mueller classification [20]
(grade 0-4, grade 4 most severe).
Diagnosis of asymptomatic sensitization was made in
sensitized AD patients who stated that they tolerated all
foods.
Atopic comorbidity
The presence of seasonal allergic rhino conjunctivitis
(AR), asthma (AA) and inhalation allergy to animal dander
was registered in order to assess the role of pollen-food
cross reactivity. Diagnosis of asthma (AA), was based on
two criteria: diagnosis made by a physician (general
practitioner or pulmonologist) and/or daily use of in-
halant corticosteroids. Diagnosis of seasonal allergic rhino
conjunctivitis (AR) and allergy to animal dander was
based on patient history and sensitization to the cor-
responding inhalant allergen on the ISAC®.








Female, n (%)† 138 (65.4) 102 (72.3) 36 (51.4) 0.003*
Age, year1,2 28.0 (22.0-44.0) 26.0 (21.0-42.0) 39.0 (26.0-49.0) < 0.001*
Total IgE, kU/L1,2,3 1455.0 (372.5-5000) 694 (171-2099) 5000 (1884.5-5000) < 0.001*
TARC, pg/mL1,2,4 1328.0 (470.0-3908.0) 743 (336.3-1683.3) 2826 (1682-7819) < 0.001*
SASSAD1,2,4 21.0 (10.0-31.0) 17.0 (8.0-27.8) 24.0 (18.0-38.0) < 0.001*
Other atopic diseases:
Asthma,5† n (%) 102 (49.8) 68 (49.3) 34 (50.7) 0.843
AR, seasonal, tree/grass,6† n (%) 131 (64.9) 88 (64.2) 43 (66.2) 0.789
AR, cat/dog,7† n (%) 100 (55.2) 67 (53.6) 33 (58.9) 0.505
1Median (IQR); 2p < 0.001; Mann–Whitney U-test; 3In subgroups mild/moderate (n = 65) versus severe AD (n = 36); 4In subgroups mild/moderate (n = 92) versus
severe AD (n = 51); 5Unknown in n = 6; 6Unknown in n = 9; 7Unknown in n = 30; *p < 0.01.
†Chi-square; mild/moderate versus severe AD.
Table 2 Proportion positive history of FA and
asymptomatic sensitization to food allergens in patients
with AD (mild/moderate versus severe AD)
Group analysis Total
n = 211 (%)
Mild/moderate AD
n = 141 (%)
Severe AD
n = 70 (%)
AD; no FA, no
sensitization
54 (25.6) 41 (29.1) 13 (18.6)
AD; no FA, only
sensitization
43 (20.4) 27 (19.1) 16 (22.9)
AD; FA supported
by sensitization
114 (54.0) 73 (51.8) 41 (58.6)
p–value = 0.26; Chi-square; mild/moderate versus severe AD.
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Statistical analysis was performed using software (SPSS
for Windows, version 19, SPSS Inc, Chicago, IL). Associ-
ations between variables were tested in contingency ta-
bles using Chi-square tests. For skewed non-categorical
data we used Mann–Whitney test. IgE measurement
using a microarray immunoassay is sensitive for a false
discovery rate by multiple testing. Therefore, adjusted
p-value < 0.01 were considered to be statistically sig-
nificant. Due to the hypothetical phase of this study no




In total 211 patients referred for evaluation of AD were
included. According to the earlier defined criteria, 141
of 211 patients (66.8%) had mild/moderate AD and 70
patients (33.2%) suffered from severe AD. Patient char-
acteristics are shown in Table 1.
The median SASSAD score and sTARC (subgroup n =
143) was 21 and 1328 pg/ml respectively. This was 17
and 743 pg/ml respectively in a subgroup of mild/mod-
erate AD patients (n = 92) and significantly lower com-
pared to the median SASSAD score of 24 and sTARC
of 2826 pg/ml in a subgroup of severe AD patients (n = 51)
(p < 0.001). Table 1 shows that also total serum-IgE levels
were significantly increased in the group of patients with
severe AD (p < 0.001).
Patients with severe AD had a significantly higher age
and were significant more often men compared to pa-
tients with mild/moderate AD (Table 1).
Distribution of asthma, seasonal allergic rhino con-
junctivitis and allergy to dog and/or cat was not signifi-
cantly different between patients with mild/moderate
and severe AD.Food sensitization and positive history of food allergy
(frequency and severity) in adult patients with atopic
dermatitis
In the total group of patients with AD food sensitization
was found in 74,4%, 54% had a positive history of FA
and 20.4% asymptomatic food sensitization (tolerant to
all foods). These percentages were not significantly dif-
ferent between the group with mild/moderate and the
group with severe AD (Table 2).
Comparison of AD patients with a positive history of
FA to AD patients with asymptomatic sensitization did
not show differences in age, sex, sTARC or total serum
IgE. In both groups sensitization to PR-10 related food
allergens was most frequent.
No significant difference in severity of FA was found
between patients with mild/moderate and severe AD.
Mueller 3 or 4 reactions occurred in 41.1% and 46.3%
of the patients with respectively mild/moderate or se-
vere AD (see Additional file 2: Table S2 in the Online
Repository).
Sensitization to food allergens of plant origin
Sensitization to any plant food allergen available in the
ISAC® microarray was found in 150 of 211 AD patients
Table 3 Sensitization (frequency and serum level) to food allergens of plant origin: selection of food allergens most










Kiwi n (%) 76 (36.0) 44 (31.2) 32 (45.7) 0.04
nAct d 1 n (%) 24 (11.4) 11 (7.8) 13 (18.6) 0.02
(cyst. protease) Median (IQR) 1.83 (0.49-10.95) 2.10 (1.06-11.32) 0.71 (0.36-13.39) 0.28
nAct d 2 n (%) 25 (11.8) 17 (12.1) 8 (11.4) 0.89
(TLP) Median (IQR) 1.92 (1.08-3.23) 1.92 (1.49-3.44) 1.36 (0.82-3.19) 0.29
nAct d 5 n (%) 1 (0.5) 0 (0) 1 (1.4) n.r.
(Kiwellin) Median (IQR) 0.62 (0.62-0.62) - 0.62 (0.62-0.62) n.r.
nAct d 8 n (%) 44 (20.9) 27 (19.1) 17 (24.3) 0.39
(PR-10) Median (IQR) 1.93 (0.76-7.17) 1.83 (0.74-3.93) 2.52 (1.12-10.81) 0.16
Peanut n (%) 119 (56.4) 74 (52.5) 45 (64.3) 0.10
nAra h 1 n (%) 24 (11.4) 9 (6.4) 15 (21.4) 0.001*
(SP) Median (IQR) 6.78 (1.45-11.83) 7.70 (3.93-17.16) 4.62 (0.95-12.09) 0.46
nAra h 2 n (%) 23 (10.9) 14 (9.9) 9 (12.9) 0.52
(SP) Median (IQR) 15.78 (5.55-35.6) 11.41 (4.89-33.30) 32.69 (8.18-56.05) 0.31
nAra h 3 n (%) 16 (7.6) 7 (5.0) 9 (12.9) 0.04
(SP) Median (IQR) 4.82 (1.0-22.66) 1.61 (0.88-42.95) 5.60 (1.33-22.26) 0.79
rAra h 8 n (%) 112 (53.1) 70 (49.6) 42 (60.0) 0.16
(PR-10) Median (IQR) 4.73 (1.66-13.02) 3.76 (1.57-9.18) 8.81 (1.85-16.16) 0.08
Hazelnut n (%) 120 (56.9) 78 (55.3) 42 (60.0) 0.52
rCor a 1.0401 n (%) 117 (55.5) 76 (53.9) 41 (58.6) 0.52
(PR-10) Median (IQR) 5.29 (2.30-12.37) 4.76 (2.18-12.0) 5.63 (2.38-16.03) 0.50
rCor a 8 n (%) 11 (5.2) 7 (5.0) 4 (5.7) n.r.
(LTP) Median (IQR) 2.78 (0.50-5.49) 2.94 (0.85-5.49) 0.81 (0.37-28.58) 0.35
nCor a 9 n (%) 12 (5.7) 9 (6.4) 3 (4.3) n.r.
(SP) Median (IQR) 1.49 (0.69-1.60) 1.50 (0.98-1.60) 0.60 (0.49-x) 0.64
Apple rMal d 1 n (%) 126 (59.7) 81 (57.4) 45 (64.3) 0.34
(PR-10) Median (IQR) 12.35 (4.50-36.50) 10.00 (3.76-29.2) 24.02 (5.35-51.38) 0.06
Peach n (%) 122 (57.8) 81 (57.4) 41 (58.6) 0.88
rPru p 1 n (%) 121 (57.3) 80 (56.7) 41 (58.6) 0.80
(PR-10) Median (IQR) 9.08 (2.73-20.78) 6.85 (2.33-13.11) 11.00 (4.18-30.61) 0.02
nPru p 3 n (%) 11 (5.2) 8 (5.7) 3 (4.3) n.r.
(LTP) Median (IQR) 4.40 (2.02-7.21) 4.70 (1.88-6.95) 2.70 (2.02-x) > 0.99
Tree PR-10 n (%) 137 (64.9) 91 (64.5) 46 (65.7) 0.87
rBet v 1 n (%) 136 (64.5) 90 (63.8) 46 (65.7) 0.79
Median (IQR) 34.97 (11.29-80.86) 32.95 (9.36-57.11) 48.5 (17.86-116.25) 0.009*
rAln g 1 n (%) 129 (61.1) 84 (59.6) 45 (64.3) 0.51
Median (IQR) 13.52 (3.37-31.13) 10.25 (3.21-29.70) 14.89 (4.42-32.04) 0.33
rCor a 1.0101 n (%) 118 (55.9) 76 (53.9) 42 (60.0) 0.40
Median (IQR) 7.00 (2.45-20.83) 7.35 (3.14-20.57) 12.50 (6.09 -22.90) 0.13
Total PR-10 n (%) 134 (63.5) 88 (62.4) 46 (65.7) 0.64
1Chi-square; mild/moderate versus severe AD; 2Mann–Whitney U-test; mild/moderate versus severe AD. *p < 0.01; n.r, non-reliable, due to small number; PR-10
protein Bet v1 homulogus; SP: storage protein; LTP: lipid transfer protein; TLP: Thaumatin-like protein.
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lergen available in the ISAC® microarray was seen most
frequently in 134 of 211 AD patients (63.5%) without
statistical difference between mild/moderate and severe
AD. We observed a significantly (p = 0.001) higher per-
centage of sensitization to the peanut allergen nAra h 1
in severe AD patients compared to mild/moderate AD
patients (Table 3).
No differences were found concerning sensitization to
nAra h 2, nAra h 3 and rAra h 8 or one of the other
plant food allergens available in the ISAC® microarray (see
Additional file 3: Table S3 in the Online Repository).
Median serum level of IgE antibodies to nAra h 1 or
other food allergens did not differ between patients with
severe AD compared to patients with mild/moderate AD
(Table 3).
Table 4 shows the number of patients with a positive
history of immediate type FA to a selection of plant food
allergens most relevant for the Dutch population. Per-
centages of a positive history of FA vary dependent on
the specific food item between 12.1% for peach and
34.8% for apple. No differences in a positive history of
FA to any plant food were found between patients with
mild/moderate AD and severe AD.
Frequency of sensitization to one or more of the PR-10
related inhalant allergens (rAln g 1, rBet v 1, rCor a
1.0101) occurred frequently (64.9%) but not different in
patients with severe AD compared to mild/moderate AD
(Table 3). A significant (p-value = 0.009) higher median
IgE serum level against rBet v 1 was found in patients with
severe AD compared to mild/moderate AD.
Sensitization to food allergens of animal origin
In the total group of patients with AD 75 patients (35.5%)
showed sensitization to any animal food allergen available
in the ISAC® microarray (Table 5). Sensitization to any
food allergen of animal origin was found in of 51.4% pa-
tients with severe AD. This was significantly (p = 0.001)
higher compared to the group with mild/moderate AD
(27.7%).Table 4 Frequency of allergy to food allergens of plant











Kiwi 37 (17.5) 25 (17.7) 12 (17.1) 0.92
Peanut 43 (20.4) 27 (19.1) 16 (22.9) 0.53
Hazelnut 35 (16.6) 24 (17.0) 11 (15.7) 0.81
Apple 70 (33.2) 49 (34.8) 21 (30.0) 0.49
Peach 28 (13.3) 17 (12.1) 11 (15.7) 0.46
1Chi-square; Mild/moderate versus severe AD.
Allergy based on positive patient history.Most frequently (24.2%) sensitization to cow’s milk
(CM) allergens was detected. Frequency of sensitization
to CM allergens differed significantly (p = 0.006) be-
tween mild/moderate and severe AD patients (18.4%
versus 35.7%). Analysis of sensitization to CM compo-
nents showed that most frequently sensitization to nBos
d lactoferrin (16.1%) and nBos d 8 (11.8%) occurred in
patients with AD. Patients with severe AD were signifi-
cantly more frequently sensitized to nBos d lactoferrin
than patients with mild/moderate AD. Median serum
levels of antibodies to CM components tended to be
higher in severe AD patients without statistical signifi-
cance according to a p-value < 0.01 (Table 5). No valid
statistical analysis could be performed regarding nBos d
4, nBos d 5 and nBos d 6 due to low patient numbers.
Frequency and median serum levels of sensitization to
hen’s egg, fish and shrimp is shown in Table 5. No difference
between mild/moderate and severe AD patients has been
observed.
A positive history of immediate type FA to animal
foods assessed by patients history is presented in Table 6.
In severe AD a positive history of FA to all animal foods
tended to be more frequent (17.1%) than in patients with
mild/moderate AD (10.6%). A positive history of FA to
CM occurred most frequently (8.5%).
CM allergy was seen in 11.4% of severe AD pa-
tients, while only in 7.1% of mild/ moderate AD pa-
tients. No valid statistical analysis could be performed
regarding hen’s egg, fish and shrimp due to low pa-
tient numbers.
50% of all CMA patients with AD reported severe symp-
toms (Mueller grade 3 or 4).
Discussion
To our knowledge, this is the first study analyzing the
pattern of food allergen sensitization using the multi-
plexed allergen microarray in adults in relation to sever-
ity of AD.
We differentiated severity of AD based on the type of
therapy patients received to control their disease (local
versus systemic) and confirmed this classification by
clinical skin scores (SASSAD) and sTARC levels. Not-
ably, patients with severe AD had a significantly higher
age than patients with mild/moderate AD, possibly due
to a larger proportion of patients with chronic severe
AD in our third line outpatient clinic.
Sensitization to food was found in 74.4% of all AD pa-
tients, 54% had a positive history of FA and 20.4% of all
patients had asymptomatic sensitization. Sensitization to
specific foods occurred two to three times more fre-
quent than a positive history of food allergy to the re-
spective food allergen. This underlines the high risk of
false positive results by unselective in-vitro testing of food
sensitization.










Cow’s milk n (%) 51 (24.2) 26 (18.4) 25 (35.7) 0.006*
nBos d 4 n (%) 10 (4.7) 8 (5.7) 2 (2.9) n.r.
(α-lactalbu.) Median (IQR) 0.54 (0.32-2.63) 0.54 (0.31-2.37) 1.60 (0.40-x) 0.60
nBos d 5 n (%) 10 (4.7) 6 (4.3) 4 (5.7) n.r.
(β-lactoglob.) Median (IQR) 1.44 (0.71-4.21) 0.89 (0.47-3.04) 2.59 (1.98-11.67) 0.06
nBos d 6 n (%) 11 (5.2) 6 (4.3) 5 (7.1) n.r.
(serum albu.) Median (IQR) 1.01 (0.53-4.04) 0.81 (0.52-5.58) 1.54 (0.59-5.89) 0.72
nBos d 8 n (%) 25 (11.8) 14 (9.9) 11 (15.7) 0.22
(casein) Median (IQR) 2.23 (1.11-5.89) 1.73 (0.80-4.75) 3.30 (1.27-8.69) 0.30
nBos d lactoferrin n (%) 34 (16.1) 16 (11.3) 18 (25.7) 0.008*
(transferrin) Median (IQR) 1.42 (0.68-2.45) 0.97 (0.50-2.05) 1.95 (1.12-2.92) 0.05
Hen’s egg n (%) 28 (13.3) 16 (11.3) 12 (17.1) 0.24
nGal d 1 n (%) 23 (10.9) 12 (8.5) 11 (15.7) 0.11
(ovomucoid) Median (IQR) 1.96 (0.63-5.19) 2.84 (1.24-5.36) 1.16 (0.46-5.19) 0.24
nGal d 2 n (%) 10 (4.7) 4 (2.8) 6 (8.6) n.r.
(ovalbumin) Median (IQR) 1.64 (0.51-3.64) 0.71 (0.42-4.69) 2.21 (1.05-6.63) 0.29
nGal d 3 n (%) 6 (2.8) 3 (2.1) 3 (4.3) n.r.
(ovotransfer.) Median (IQR) 1.08 (0.68-2.68) 0.78 (0.69-x) 2.04 (0.63-x) 0.51
nGal d 5 n (%) 4 (1.9) 0 (0) 4 (5.7) n.r.
(serum albu.) Median (IQR) 0.43 (0.31-094) - 0.43 (0.31-094) -
Fish n (%) 24 (11.4) 12 (8.5) 12 (17.1) 0.06
rCyp c 1 n (%) 23 (10.9) 12 (8.5) 11 (15.7) 0.11
(parvalb.) Median (IQR) 2.43 (0.50-15.0) 2.00 (0.45-8.80) 2.43 (0.50-21.78) 0.30
rGad c 1 n (%) 13 (6.2) 5 (3.5) 8 (11.4) n.r.
(parvalb.) Median (IQR) 4.96 (2.47-7.85) 5.80 (4.65-7.85) 3.71 (0.93-18.72) 0.24
Shrimp n (%) 15 (7.1) 5 (3.5) 10 (14.3) n.r.
rPen a 1 n (%) 8 (3.8) 2 (1.4) 6 (8.6) n.r.
(tropomyosin) Median (IQR) 10.18 (1.24-33.22) 28.44 (18.87-x) 3.85 (0.54-37.20) 0.18
nPen i 1 n (%) 11 (5.2) 4 (2.8) 7 (10.0) n.r.
(tropomyosin) Median (IQR) 5.33 (1.50-26.0) 11.08 (0.91-40.31) 5.33 (1.50-26.0) 0.85
nPen m 1 n(%) 13 (6.2) 4 (2.8) 9 (12.9) n.r.
(tropomyosin) Median (IQR) 5.14 (0.48-30.46) 11.24 (0.39-43.73) 5.14 (0.70-23.89) > 0.99
Total3 n (%) 75 (35.5) 39 (27.7) 36 (51.4) 0.001*
1Chi-square; mild/moderate versus severe AD. *p < 0.01.; 2Mann–Whitney U-test; mild/moderate versus severe AD.
3Frequency of sensitization to any of the animal allergens. n.r, non-reliable, due to small number.
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common food or inhalant allergen (apart from Bet v 1,
which was only moderate). Therefore, the considerable
difference of total IgE between mild/moderate and severe
AD, cannot be explained by specific IgE sensitization. Re-
markably, there was no association between severity of
AD and frequency of food sensitization or a positive his-
tory of FA. Only one study in infants related AD severity,
differentiated by duration of topical steroid usage, to thepresence of food sensitization and FA. This study ob-
served an increased frequency of sensitization to food
(measured by SPT) and immediate type FA (parents re-
ported) with increased AD severity [21].
The majority of studies on the prevalence of food
sensitization in patients with AD were performed in
children using SPT or CAP and show varying rates up
to 86% [6,22-24]. A recent study [25] using ISAC® micro
array in 140 children with AD (mean age 74 months)
Table 6 Frequency of allergy to food allergens of animal
origin
Allergen Total Mild/moderate AD Severe AD P-
value1n = 211 (%) n = 141 (%) n = 70 (%)
Cow’s milk 18 (8.5) 10 (7.1) 8 (11.4) 0.29
Hen’s egg 12 (5.7) 11 (7.8) 1 (1.4) n.r
Fish 8 (3.8) 4 (2.8) 4 (5.7) n.r
Shrimp 4 (1.9) 2 (1.4) 2 (2.9) n.r.
Total2 27 (12.8) 15 (10.6) 12 (17.1) 0.18
1Chi-square; mild/moderate AD versus severe AD.
2Allergy to cow’s milk or hen’s egg or fish or shrimp.
n.r, non-reliable, due to small number.
Allergy based on positive patient history.
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differences in AD severity. Sensitization to hen’s egg was
found most commonly in 35%, followed by sensitization to
apple (23%), hazelnut (22%), kiwi (15%) and CM (14%).
Studies investigating the co-prevalence of AD and food
sensitization or FA in adults are scarce and difficult to com-
pare due to different study designs [7,9]. Only one small
study [11] reported IgE profiling using ISAC® micro array
in adult AD patients (n = 20), 70% (n = 14) of them with
severe AD. Results show a sensitization frequency of 70%
to PR-10 related food allergens, 45% to animal food and
30% to CM allergens, being in accordance with our data.
In our study, sensitization to PR-10 related plant food
allergens were most frequent. This corresponded with a
high frequency of seasonal rhino conjunctivitis. How-
ever, no difference in PR-10 related plant food allergen
sensitization was seen between mild/moderate and se-
vere AD patients. Analysis of the allergen sensitization
pattern shows that this is most likely due to pollen
cross-reactivity [26-28]. However, severe AD patients
showed a higher sensitization rate to the plant allergen
nAra h 1 (major peanut allergen), which is not pollen
cross-reactive [29]. However, there was no difference in
nAra h 1 median IgE serum level or history of immedi-
ate type FA to peanut. The study of Ott et al. [11] using
ISAC® micro array reported only one patient (5%) in their
adult AD population with sensitization to nAra h 1 with-
out further differentiation of AD severity. In children with
AD a high rate of sensitization to peanut (varying between
33% en 86%), analyzed by SPT and/or CAP was reported
[22-24]. Data specific for nAra h 1 sensitization were
not available.
In the total group of patients with AD 35.5% showed
sensitization to any animal food allergen. The percentage
was significantly higher in patients with severe AD (51.4%)
compared to patients with mild/moderate AD (27.7%).
However, no difference in serum levels of any animal aller-
gen was observed. In severe AD patients, sensitization to
the CM allergens (35.7%), in particular to nBos d lactofer-
rin (25.7%), was observed more frequently compared topatients with mild/moderate AD (18.4% and 11.3% re-
spectively). A comparable rate of sensitization to animal
food and CM measured by ISAC® microarray was shown
previously in a small population [11] (n = 20) of adult
AD patients without differentiation of severity. Not-
ably, in this study the microarray did not contain
lactoferrin and sensitization to nBos d 6 was seen most
frequently (30%). This is different from our results,
where sensitization to nBos d 6 was found in 5.2% of
the population.
Frequency of a positive history of FA to all animal food
was 12.8% and for CM 8.5%. Both tended to be more
frequent in severe AD patients (17.1% and 11.4%, re-
spectively). In adults we previously described a frequent
co-prevalence of AD and CM allergy [30]. A recent obser-
vational study by Wood et al. [31] on children (n = 244;
age 3-15 month) showed a much higher rate of resolution
of CM allergy in infants with mild compared to severe
AD, indicating that moderate to severe AD in childhood is
highly predictive of persistent CM allergy.
Conclusion
In conclusion, our results show that in this Dutch popu-
lation of adult patients with AD sensitization to PR-10
related plant food allergens occurred most frequently,
but independent from AD severity. In contrast, we found
a higher sensitization rate to animal food, in particular
CM in severe AD in adults. These findings need to be
reproduced in a prospective study.
Limitations
The retrospective design of this study is sensitive to
missing data and may result in an underestimation of
current frequency of FA. Since all patients have been re-
ferred for evaluation of AD, FA was not proven by food
challenge but patient history by an experienced phys-
ician. Another limitation may be the recruitment of this
population from a tertiary university center, which pos-
sibly results in a certain degree of selection bias.
At present there are limited data on the sensitivity and
specificity of the separate allergen components of the
ISAC® microarray compared to conventional methods
like CAP.
Finally, the results might be influenced by geographical
factors such as pollen exposure and eating habits and can
possibly not generalized to al AD patient populations.Additional files
Additional file 1: Table S1. Allergens available on ImmunoCAP ISAC®
microarray.
Additional file 2: Table S2. Severity of FA by Mueller classification in
patients with AD (mild/moderate versus severe AD).
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to food allergens of plant origin (additional allergens).
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